New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2014
08:35 EDTNPSPNPS Pharmaceuticals receives orphan drug designation for Natpara in Europe
NPS Pharmaceuticals announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism. Orphan drug designation in the European Union is given to products that are designed for the diagnosis, prevention or treatment of rare diseases that are life-threatening or chronically debilitating. The company was also granted orphan drug status by the U.S. Food and Drug Administration in 2007. The company submitted its U.S. Biologic License Application to FDA in October 2013.
News For NPSP From The Last 14 Days
Check below for free stories on NPSP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
11:41 EDTNPSPCubist rises after report sparks takeover interest speculation
Subscribe for More Information
August 15, 2014
10:01 EDTNPSPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:12 EDTNPSPNPS Pharmaceuticals initiated with an Outperform at FBR Capital
Target $34.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use